Clinical Trials for MaaT Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MaaT Pharma

Clinical Trials (4)

NCT07001618
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
PHASE2Not yet recruiting
162 participants
Started: Sep 30, 2025 · Completed: Sep 30, 2032
1 condition3 sponsors1 location
NCT05762211
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
PHASE2Recruiting
387 participants
Started: Oct 31, 2023 · Completed: Feb 15, 2027
1 condition1 sponsor54 locations
NCT04769895
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
PHASE3Active, not recruiting
66 participants
Started: Mar 25, 2022 · Completed: Nov 30, 2025
2 conditions1 sponsor50 locations
NCT05017688
Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013
NARecruiting
40 participants
Started: Oct 6, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor9 locations